risperidone has been researched along with Delusional Disorder in 94 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
Delusional Disorder: Disorder with presentation of a facade of coldness with characteristic pervasive mistrust and suspiciousness of others.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In this 4-week, double-blind, randomized controlled trial conducted in psychiatric care from September 2012 to March 2015, 103 patients with schizophrenia (ICD-10) who did not respond to olanzapine 10 mg/d or risperidone 3 mg/d were randomly allocated to a dose-increment or -continuation group." | 9.22 | Increasing Versus Maintaining the Dose of Olanzapine or Risperidone in Schizophrenia Patients Who Did Not Respond to a Modest Dosage: A Double-Blind Randomized Controlled Trial. ( Bies, RR; Kapur, S; Mimura, M; Pollock, BG; Sakurai, H; Suzuki, T; Uchida, H, 2016) |
| "In two double-blind trials conducted in North America, 513 patients with chronic schizophrenia received risperidone, haloperidol, or placebo." | 9.08 | The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: combined results of the North American trials. ( Chouinard, G; Davis, JM; Marder, SR, 1997) |
| "A 39-year-old man with schizophrenia developed severe catatonia, hyperthermia, muscle rigidity, tachycardia, leukocytosis, and elevated muscle enzyme levels while receiving zotepine therapy." | 7.73 | Zotepine-induced catatonia as a precursor in the progression to neuroleptic malignant syndrome. ( Chen, CC; Tsai, JH; Yang, MJ; Yang, P; Yen, JY, 2005) |
| "A follow-up of a case of pregnancy with risperidone microspheres is reported." | 7.73 | Follow-up of a pregnancy with risperidone microspheres. ( Dabbert, D; Heinze, M, 2006) |
| " This woman developed severe catatonia under medication with a serotonergic/dopaminergic neuroleptic, risperidone, at a dose of up to 5 mg daily." | 7.70 | Catatonia under medication with risperidone in a 61-year-old patient. ( Bahro, M; Kämpf, C; Strnad, J, 1999) |
| "We report a 5-case series in which risperidone use in usual or lower-than-usual doses was unexpectedly associated with amenorrhea." | 7.70 | Risperidone and associated amenorrhea: a report of 5 cases. ( Kim, L; Kim, YK; Lee, MS, 1999) |
| "Risperidone is a second-generation atypical antipsychotic and there have been case reports of risperidone-associated deep vein thrombosis, most of them reporting the complication from 2 weeks to a few months of initiation of therapy." | 5.62 | Deep vein thrombosis on the fourth day of risperidone therapy. ( George, M; Konnakkaparambil Ramakrishnan, K, 2021) |
| "In this 4-week, double-blind, randomized controlled trial conducted in psychiatric care from September 2012 to March 2015, 103 patients with schizophrenia (ICD-10) who did not respond to olanzapine 10 mg/d or risperidone 3 mg/d were randomly allocated to a dose-increment or -continuation group." | 5.22 | Increasing Versus Maintaining the Dose of Olanzapine or Risperidone in Schizophrenia Patients Who Did Not Respond to a Modest Dosage: A Double-Blind Randomized Controlled Trial. ( Bies, RR; Kapur, S; Mimura, M; Pollock, BG; Sakurai, H; Suzuki, T; Uchida, H, 2016) |
| "In two double-blind trials conducted in North America, 513 patients with chronic schizophrenia received risperidone, haloperidol, or placebo." | 5.08 | The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: combined results of the North American trials. ( Chouinard, G; Davis, JM; Marder, SR, 1997) |
| "Adult Maryland Medicaid patients with schizophrenia were categorized based on initial atypical antipsychotic drug received: aripiprazole (n=446); olanzapine (n=1705); quetiapine (n=1467); risperidone (n=1580); and ziprasidone (n=700)." | 3.74 | Risk of discontinuation of atypical antipsychotic agents in the treatment of schizophrenia. ( Cuffel, BJ; Loebel, AD; Mullins, CD; Naradzay, J; Obeidat, NA, 2008) |
| "A 39-year-old man with schizophrenia developed severe catatonia, hyperthermia, muscle rigidity, tachycardia, leukocytosis, and elevated muscle enzyme levels while receiving zotepine therapy." | 3.73 | Zotepine-induced catatonia as a precursor in the progression to neuroleptic malignant syndrome. ( Chen, CC; Tsai, JH; Yang, MJ; Yang, P; Yen, JY, 2005) |
| "A follow-up of a case of pregnancy with risperidone microspheres is reported." | 3.73 | Follow-up of a pregnancy with risperidone microspheres. ( Dabbert, D; Heinze, M, 2006) |
| " This woman developed severe catatonia under medication with a serotonergic/dopaminergic neuroleptic, risperidone, at a dose of up to 5 mg daily." | 3.70 | Catatonia under medication with risperidone in a 61-year-old patient. ( Bahro, M; Kämpf, C; Strnad, J, 1999) |
| "We report a 5-case series in which risperidone use in usual or lower-than-usual doses was unexpectedly associated with amenorrhea." | 3.70 | Risperidone and associated amenorrhea: a report of 5 cases. ( Kim, L; Kim, YK; Lee, MS, 1999) |
| "We report a 2-year experience with olanzapine treatment (20 mg daily) in a 65-year-old male patient with treatment-resistant paranoid schizophrenia, who had previously developed leucopenia and neutropenia first on clozapine and, subsequently, also on risperidone." | 3.70 | Olanzapine appears haematologically safe in patients who developed blood dyscrasia on clozapine and risperidone. ( Dernovsek, MZ; Tavcar, R, 2000) |
| "56 male subjects with paranoid schizophrenia were included in the study." | 2.77 | Double-blind placebo-controlled randomized efficacy and safety trial of add-on treatment of dimebon plus risperidone in schizophrenic patients during transition from acute psychotic episode to remission. ( Beniashvili, AG; Lepilkina, TA; Morozova, MA; Rupchev, GE, 2012) |
| "Twenty-four female patients with paranoid schizophrenia and 15 healthy females were recruited." | 2.74 | Improvement in social competence in patients with schizophrenia: a pilot study using a performance-based measure using virtual reality. ( Kim, JJ; Kim, SI; Ku, J; Park, IH; Park, JY; Park, KM, 2009) |
| "Risperidone is a second-generation atypical antipsychotic and there have been case reports of risperidone-associated deep vein thrombosis, most of them reporting the complication from 2 weeks to a few months of initiation of therapy." | 1.62 | Deep vein thrombosis on the fourth day of risperidone therapy. ( George, M; Konnakkaparambil Ramakrishnan, K, 2021) |
| "Thirty-three patients with paranoid schizophrenia and 18 patients with AD were included in the study." | 1.56 | [Antioxidant status in patients with paranoid schizophrenia and Alzheimer disease]. ( Grishina, NK; Khannanova, AN; Portnova, GV; Proskurnina, EV; Sokolova, SV; Sozarukova, MM, 2020) |
| "A total 52 first-episode and drug-naive paranoid schizophrenia patients who were treated with risperidone and 53 matched healthy controls were enrolled." | 1.46 | Successful treatment with risperidone increases 5-HT 3A receptor gene expression in patients with paranoid schizophrenia - data from a prospective study. ( Chen, H; Fan, Y; Guan, Y; Hao, Y; Li, Z; Zhao, L; Zhou, X, 2017) |
| "We examined 42 patients with paranoid schizophrenia." | 1.42 | [Lipid spectrum changes and ECG in patients with paranoid schizophrenia in the course of therapy with atypical antipsychotics]. ( Borodyuk, YN; Burdovitsina, TG; Kornetova, EG; Parshukova, DA; Semke, AV; Seregin, AA; Smirnova, LP; Tkacheva, GD, 2015) |
| "We describe an adult patient with a lacunar infarct in the posterior region of the right thalamus exhibiting a paranoid schizophrenia-like psychosis as the only clinical manifestation." | 1.39 | Schizophrenia-like psychosis associated with right lacunar thalamic infarct. ( Atriano-Mendieta, C; Carrillo-Meza, R; Crail-Melendez, D; Ramirez-Bermudez, J, 2013) |
| "Pimozide has been mooted as specific for the treatment of this condition." | 1.36 | Atypical anti-psychotics in delusional parasitosis: a retrospective case series of 20 patients. ( Kenchaiah, BK; Kumar, S; Tharyan, P, 2010) |
| "Tardive seizure is a serious adverse reaction of electroconvulsive therapy (ECT)." | 1.35 | Tardive seizure and antibiotics: case reports and review of the literature. ( Isse, K; Nakamura, M; Saito, T; Watari, M, 2008) |
| "Treatment with risperidone solution orally or parenteral haloperidol until the day after admission, followed by olanzapine, successfully improved the clinical condition of the patients." | 1.35 | Three cases of schizophrenia for which olanzapine was effective after early acute phase. ( Inada, T; Oda, T; Yamamoto, N, 2008) |
| "Fifty-eight patients with first-episode paranoid schizophrenia were treated with either clozapine or risperidone, and before and at the end of the 4th, 8th weeks and 6th months after the medication respectively, the serum levels of interleukin (IL)-6, 2, 18,and tumor necrosis factor (TNF)alpha were measured with enzyme-linked immunosorbent assay (ELISA)." | 1.32 | [Effect of clozapine and risperidone on serum cytokine levels in patients with first-episode paranoid schizophrenia]. ( Chen, W; Cheng, J; Guo, JH; Guo, SQ; Li, Q; Lü, LX, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 26 (27.66) | 18.2507 |
| 2000's | 42 (44.68) | 29.6817 |
| 2010's | 24 (25.53) | 24.3611 |
| 2020's | 2 (2.13) | 2.80 |
| Authors | Studies |
|---|---|
| Sokolova, SV | 1 |
| Sozarukova, MM | 1 |
| Khannanova, AN | 1 |
| Grishina, NK | 1 |
| Portnova, GV | 1 |
| Proskurnina, EV | 1 |
| Konnakkaparambil Ramakrishnan, K | 1 |
| George, M | 1 |
| Kulkarni, K | 1 |
| Arasappa, R | 1 |
| Prasad M, K | 1 |
| Zutshi, A | 1 |
| Chand, PK | 1 |
| Murthy, P | 1 |
| Philip, M | 1 |
| Muralidharan, K | 1 |
| Kuppili, PP | 2 |
| Gupta, R | 1 |
| Pattanayak, RD | 1 |
| Khandelwal, SK | 1 |
| Chen, H | 1 |
| Fan, Y | 1 |
| Zhao, L | 1 |
| Hao, Y | 1 |
| Zhou, X | 1 |
| Guan, Y | 1 |
| Li, Z | 1 |
| Prakash, S | 1 |
| Sinha Deb, K | 1 |
| Chadda, RK | 1 |
| Bhattacharjee, D | 1 |
| Yerrapragada, D | 1 |
| Chogtu, B | 1 |
| Thomson, SR | 1 |
| Jarczak, D | 1 |
| Kluge, S | 1 |
| Fuhrmann, V | 1 |
| Smirnova, LP | 1 |
| Parshukova, DA | 1 |
| Borodyuk, YN | 1 |
| Kornetova, EG | 1 |
| Tkacheva, GD | 1 |
| Seregin, AA | 1 |
| Burdovitsina, TG | 1 |
| Semke, AV | 1 |
| Ganesh, M | 1 |
| Jabbar, U | 1 |
| Iskander, FH | 1 |
| Hefner, G | 1 |
| Falter, T | 1 |
| Bruns, K | 1 |
| Hiemke, C | 1 |
| Sakurai, H | 1 |
| Suzuki, T | 1 |
| Bies, RR | 1 |
| Pollock, BG | 1 |
| Mimura, M | 1 |
| Kapur, S | 1 |
| Uchida, H | 1 |
| Saito, T | 1 |
| Nakamura, M | 1 |
| Watari, M | 1 |
| Isse, K | 1 |
| Ghaznavi, S | 1 |
| Nakic, M | 1 |
| Rao, P | 1 |
| Hu, J | 1 |
| Brewer, JA | 1 |
| Hannestad, J | 1 |
| Bhagwagar, Z | 1 |
| Molina, JD | 1 |
| Solé, S | 1 |
| Pablo, Sd | 1 |
| López-Muñoz, F | 1 |
| Santana, G | 1 |
| Alamo, C | 1 |
| Mall, GD | 1 |
| Hake, L | 1 |
| Benjamin, AB | 1 |
| Adityanjee, A | 1 |
| Pelizza, L | 1 |
| Gorobets, LN | 1 |
| Peritogiannis, V | 1 |
| Tsouli, S | 1 |
| Moga, DE | 1 |
| Cabaniss, DL | 1 |
| Marcus, ER | 1 |
| Walsh, BT | 1 |
| Kahn, DA | 1 |
| Park, KM | 1 |
| Ku, J | 1 |
| Park, IH | 1 |
| Park, JY | 1 |
| Kim, SI | 1 |
| Kim, JJ | 1 |
| Batalla, A | 1 |
| Vera, M | 1 |
| Torra, M | 1 |
| Parellada, E | 1 |
| Alexander, J | 1 |
| Campbell, P | 1 |
| Kenchaiah, BK | 1 |
| Kumar, S | 1 |
| Tharyan, P | 2 |
| Guénolé, F | 1 |
| Hardan, AY | 1 |
| Fung, LK | 1 |
| Amin, H | 1 |
| Chen, CC | 2 |
| Huang, TL | 1 |
| Létourneau, G | 1 |
| Abdel-Baki, A | 1 |
| Dubreucq, S | 1 |
| Mahone, M | 1 |
| Granger, B | 1 |
| Yang, HN | 1 |
| Cheng, YM | 1 |
| Crail-Melendez, D | 1 |
| Atriano-Mendieta, C | 1 |
| Carrillo-Meza, R | 1 |
| Ramirez-Bermudez, J | 1 |
| Morozova, MA | 1 |
| Beniashvili, AG | 1 |
| Lepilkina, TA | 1 |
| Rupchev, GE | 1 |
| Güneş, F | 1 |
| Batgi, H | 1 |
| Akbal, A | 1 |
| Canatan, T | 1 |
| Katz, N | 1 |
| Zemishlany, Z | 1 |
| Weizman, A | 4 |
| Shimizu, E | 1 |
| Watanabe, H | 1 |
| Iyo, M | 1 |
| Beauchemin, MA | 1 |
| Millaud, F | 1 |
| Nguyen, KA | 1 |
| Molina, V | 1 |
| Gispert, JD | 1 |
| Reig, S | 1 |
| Sanz, J | 1 |
| Pascau, J | 1 |
| Santos, A | 1 |
| Palomo, T | 1 |
| Desco, M | 1 |
| Loh, C | 1 |
| Leckband, SG | 1 |
| Meyer, JM | 1 |
| Turner, E | 1 |
| Karama, S | 1 |
| Lal, S | 1 |
| Nechifor, M | 1 |
| Vaideanu, C | 1 |
| Palamaru, I | 1 |
| Borza, C | 1 |
| Mindreci, I | 1 |
| Lü, LX | 1 |
| Guo, SQ | 1 |
| Chen, W | 1 |
| Li, Q | 1 |
| Cheng, J | 1 |
| Guo, JH | 1 |
| Esposito, D | 2 |
| Corruble, E | 2 |
| Hardy, P | 2 |
| Chouinard, G | 3 |
| Brocvielle, H | 1 |
| Becquemont, L | 1 |
| Tsai, JH | 1 |
| Yang, P | 1 |
| Yen, JY | 1 |
| Yang, MJ | 1 |
| Narumoto, J | 1 |
| Ueda, H | 1 |
| Tsuchida, H | 1 |
| Yamashita, T | 1 |
| Kitabayashi, Y | 1 |
| Fukui, K | 1 |
| Lindenmayer, JP | 1 |
| Parak, M | 1 |
| Gorman, JM | 1 |
| Wu, PL | 1 |
| Lane, HY | 1 |
| Su, KP | 1 |
| Raviña, T | 1 |
| Raviña, P | 1 |
| Gutierrez, J | 1 |
| Lin, SK | 1 |
| Chen, CK | 1 |
| Dabbert, D | 1 |
| Heinze, M | 1 |
| Panagiotidis, PT | 1 |
| Fountoulakis, KN | 1 |
| Siamouli, M | 1 |
| Magiria, S | 1 |
| Iacovides, A | 1 |
| Kaprinis, G | 1 |
| Segal, M | 1 |
| Avital, A | 1 |
| Derevenski, A | 1 |
| Berstein, S | 1 |
| Sandbank, S | 1 |
| Rajkumar, AP | 1 |
| Jebaraj, P | 1 |
| Mullins, CD | 1 |
| Obeidat, NA | 1 |
| Cuffel, BJ | 1 |
| Naradzay, J | 1 |
| Loebel, AD | 1 |
| Mercan, S | 1 |
| Altunay, IK | 1 |
| Taskintuna, N | 1 |
| Ogutcen, O | 1 |
| Kayaoğlu, S | 1 |
| Sahoo, S | 1 |
| Ameen, S | 1 |
| Akhtar, S | 1 |
| Lin, YY | 1 |
| Chu, SJ | 1 |
| Tsai, SH | 1 |
| Radics, J | 1 |
| Yamamoto, N | 1 |
| Oda, T | 1 |
| Inada, T | 1 |
| Koreen, AR | 1 |
| Lieberman, JA | 1 |
| Kronig, M | 1 |
| Cooper, TB | 1 |
| Heinrich, K | 1 |
| Klieser, E | 1 |
| Lehmann, E | 1 |
| Kinzler, E | 1 |
| Hruschka, H | 1 |
| Emes, CE | 1 |
| Millson, RC | 1 |
| O'Croinin, F | 1 |
| Zibin, T | 1 |
| Holt, L | 1 |
| McCarthy, RH | 1 |
| Terkelsen, KG | 1 |
| Singer, S | 1 |
| Richards, C | 1 |
| Boland, RJ | 1 |
| Lacey, RL | 1 |
| Preskorn, SH | 1 |
| Jerkovich, GS | 1 |
| Faulk, RS | 1 |
| Gilmore, JH | 1 |
| Jensen, EW | 1 |
| Perkins, DO | 1 |
| Penn, JV | 1 |
| Martini, J | 1 |
| Radka, D | 1 |
| Anand, VS | 1 |
| Dewan, MJ | 1 |
| Lübbe, R | 1 |
| Brody, AL | 1 |
| Solon, EN | 1 |
| Alzaid, K | 1 |
| Jones, BD | 1 |
| Whitten, JR | 1 |
| Ruehter, VL | 1 |
| Marder, SR | 1 |
| Davis, JM | 1 |
| Finkel, B | 2 |
| Lerner, AG | 1 |
| Oyffe, I | 2 |
| Sigal, M | 2 |
| Lerner, A | 1 |
| Rudinski, D | 1 |
| Shiwach, RS | 1 |
| Carmody, TJ | 1 |
| Benazzi, F | 1 |
| Villanueva Lamas, J | 1 |
| García García, J | 1 |
| Alda Diez, JA | 1 |
| Tous Andreu, N | 1 |
| Levin, T | 1 |
| Heresco-Levy, U | 1 |
| Bahro, M | 1 |
| Kämpf, C | 1 |
| Strnad, J | 1 |
| Kim, YK | 1 |
| Kim, L | 1 |
| Lee, MS | 1 |
| Hori, M | 1 |
| Shiraishi, H | 1 |
| Künstler, U | 1 |
| Hohdorf, K | 1 |
| Regenthal, R | 1 |
| Seese, A | 1 |
| Gertz, HJ | 1 |
| Kelly, BD | 1 |
| Kennedy, N | 1 |
| Shanley, D | 1 |
| Safer, DL | 1 |
| Wenegrat, B | 1 |
| Roth, WT | 1 |
| Dernovsek, MZ | 1 |
| Tavcar, R | 1 |
| Bassitt, DP | 1 |
| de Souza Lobo Garcia, L | 1 |
| Shiloh, R | 1 |
| Weizer, N | 1 |
| Dorfman-Etrog, P | 1 |
| Munitz, H | 1 |
| Cordeiro, Q | 1 |
| Elkis, H | 1 |
| Kores Plesnicar, B | 1 |
| Vitorovic, S | 1 |
| Zalar, B | 1 |
| Tomori, M | 1 |
| Freudenreich, O | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Risperidone Versus Haloperidol Versus Placebo in the Treatment of Chronic Schizophrenia[NCT00249132] | Phase 3 | 523 participants (Actual) | Interventional | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for risperidone and Delusional Disorder
| Article | Year |
|---|---|
Acute Laryngeal Dystonia With Novel Antipsychotics: A Case Report and Review of Literature.
Topics: Acute Disease; Aged; Antipsychotic Agents; Dystonia; Humans; Laryngeal Diseases; Male; Risperidone; | 2015 |
Peripheral edema associated with risperidone oral solution: a case report and a review of the literature.
Topics: Administration, Oral; Antipsychotic Agents; Commitment of Mentally Ill; Edema; Female; Humans; Injec | 2012 |
Delusion and desire: erotomania revisited.
Topics: Antipsychotic Agents; Female; Hospitalization; Humans; Middle Aged; Risperidone; Schizophrenia, Para | 2000 |
7 trials available for risperidone and Delusional Disorder
| Article | Year |
|---|---|
Increasing Versus Maintaining the Dose of Olanzapine or Risperidone in Schizophrenia Patients Who Did Not Respond to a Modest Dosage: A Double-Blind Randomized Controlled Trial.
Topics: Adult; Aged; Benzodiazepines; Dose-Response Relationship, Drug; Double-Blind Method; Drug Resistance | 2016 |
Improvement in social competence in patients with schizophrenia: a pilot study using a performance-based measure using virtual reality.
Topics: Adolescent; Adult; Analysis of Variance; Antipsychotic Agents; Aripiprazole; Diagnosis, Computer-Ass | 2009 |
Double-blind placebo-controlled randomized efficacy and safety trial of add-on treatment of dimebon plus risperidone in schizophrenic patients during transition from acute psychotic episode to remission.
Topics: Acute Disease; Adult; Antipsychotic Agents; Cognition Disorders; Drug Therapy, Combination; Humans; | 2012 |
The influence of some antipsychotics on erythrocyte magnesium and plasma magnesium, calcium, copper and zinc in patients with paranoid schizophrenia.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Biomarkers; Calcium; Copper; Erythrocytes; Female; Ha | 2004 |
Prolactin serum levels in paranoid versus nonparanoid male schizophrenia patients treated with risperidone.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Dopamine Antagonists; Humans; Hyperprolactinemia; Mal | 2007 |
Risperidone versus clozapine in the treatment of schizophrenic patients with acute symptoms: a double blind, randomized trial.
Topics: Acute Disease; Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Clozapine; Double-Blind Me | 1994 |
The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: combined results of the North American trials.
Topics: Adolescent; Adult; Aged; Basal Ganglia Diseases; Dose-Response Relationship, Drug; Double-Blind Meth | 1997 |
84 other studies available for risperidone and Delusional Disorder
| Article | Year |
|---|---|
[Antioxidant status in patients with paranoid schizophrenia and Alzheimer disease].
Topics: Alzheimer Disease; Antioxidants; Antipsychotic Agents; Clozapine; Humans; Risperidone; Schizophrenia | 2020 |
Deep vein thrombosis on the fourth day of risperidone therapy.
Topics: Antipsychotic Agents; Benzodiazepines; Humans; Male; Risperidone; Schizophrenia, Paranoid; Venous Th | 2021 |
Risperidone versus olanzapine in the acute treatment of Persistent Delusional Disorder: A retrospective analysis.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Chlorpromazine; Female; Humans; Logistic Models; Male; | 2017 |
Delusional denial of pregnancy: Unique presentation of Cotard's syndrome in a patient with schizophrenia.
Topics: Adult; Antipsychotic Agents; Delusions; Denial, Psychological; Female; Humans; Pregnancy; Pregnancy | 2017 |
Successful treatment with risperidone increases 5-HT 3A receptor gene expression in patients with paranoid schizophrenia - data from a prospective study.
Topics: Adult; Antipsychotic Agents; Drug Monitoring; Female; Gene Expression; Humans; Male; Pharmacogenomic | 2017 |
Being 80% female and 20% male: Delusional pseudotransexualism in a case of Schizophrenia.
Topics: Antipsychotic Agents; Delusions; Female; Humans; Male; Risperidone; Schizophrenia, Paranoid; Schizop | 2018 |
Risperidone Induced Isolated Thrombocytopenia: A Rare Adverse Event.
Topics: Adult; Antipsychotic Agents; Humans; Male; Risperidone; Schizophrenia, Paranoid; Thrombocytopenia | 2018 |
Successful therapy of massive risperidone-induced rhabdomyolysis using different dialysis and adsorber devices: A case report.
Topics: Adult; Antipsychotic Agents; Humans; Male; Renal Dialysis; Rhabdomyolysis; Risperidone; Schizophreni | 2019 |
[Lipid spectrum changes and ECG in patients with paranoid schizophrenia in the course of therapy with atypical antipsychotics].
Topics: Adult; Antipsychotic Agents; Atherosclerosis; Benzodiazepines; Dibenzothiazepines; Electrocardiograp | 2015 |
Elevated risperidone serum concentrations during acute inflammation, two cases.
Topics: Acute Disease; Adult; Antipsychotic Agents; C-Reactive Protein; Female; Humans; Inflammation; Middle | 2015 |
Tardive seizure and antibiotics: case reports and review of the literature.
Topics: Anti-Bacterial Agents; Antipsychotic Agents; Electroconvulsive Therapy; Electroencephalography; Huma | 2008 |
Rechallenging with clozapine following neutropenia: treatment options for refractory schizophrenia.
Topics: Antipsychotic Agents; Clozapine; Drug Resistance; Drug Therapy, Combination; Humans; Male; Middle Ag | 2008 |
Rapid onset psychosis after reduction of the risperidone dose.
Topics: Adult; Antipsychotic Agents; Humans; Male; Psychotic Disorders; Risperidone; Schizophrenia, Paranoid | 2008 |
Catatonia and mild neuroleptic malignant syndrome after initiation of long-acting injectable risperidone: case report.
Topics: Antipsychotic Agents; Catatonia; Delayed-Action Preparations; Female; Humans; Injections, Intramuscu | 2008 |
Long-acting risperidone-induced periorbital edema.
Topics: Adult; Antipsychotic Agents; Delayed-Action Preparations; Edema; Eyelid Diseases; Female; Humans; In | 2008 |
Contribution of leptin to the formation of neuroleptic obesity in patients with schizophrenia during antipsychotic therapy.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Female; Humans; Leptin; Male; Obesity; Olan | 2008 |
Can atypical antipsychotics improve tardive dyskinesia associated with other atypical antipsychotics? Case report and brief review of the literature.
Topics: Adult; Anti-Dyskinesia Agents; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; | 2010 |
Religious delusions in an evangelical Christian woman with anorexia nervosa.
Topics: Adult; Anorexia Nervosa; Antipsychotic Agents; Behavior Therapy; Benzodiazepines; Female; Hospitaliz | 2009 |
The combined use of risperidone long-acting injection and clozapine in patients with schizophrenia non-adherent to clozapine: a case series.
Topics: Adult; Antipsychotic Agents; Clozapine; Delayed-Action Preparations; Drug Therapy, Combination; Fema | 2010 |
Antipsychotic treatment in a patient with schizophrenia undergoing hemodialysis.
Topics: Antipsychotic Agents; Drug Monitoring; Female; Humans; Middle Aged; Renal Dialysis; Renal Insufficie | 2010 |
SSRIs as a treatment alternative for monosymptomatic delusional disorders.
Topics: Adult; Benzodiazepines; Cognitive Behavioral Therapy; Humans; Male; Olanzapine; Psychiatric Status R | 2010 |
Looking at ordinary people's tales of living with their mental illness. Interview by Alita Howe.
Topics: Antipsychotic Agents; Black People; Commitment of Mentally Ill; Humans; Ill-Housed Persons; Risperid | 2010 |
Atypical anti-psychotics in delusional parasitosis: a retrospective case series of 20 patients.
Topics: Antipsychotic Agents; Benzodiazepines; Ectoparasitic Infestations; Female; Fluoxetine; Haloperidol; | 2010 |
[Oniric activity in the onset of psychosis: the dreams of a schizophrenic].
Topics: Aggression; Antipsychotic Agents; Cognition Disorders; Delusions; Dreams; Female; Humans; Neuropsych | 2010 |
Risperidone: switching from brand name to generic.
Topics: Adolescent; Antipsychotic Agents; Autistic Disorder; Child; Drugs, Generic; Female; Humans; Male; Ri | 2010 |
Effects of antipsychotics on the serum BDNF levels in schizophrenia.
Topics: Adult; Antipsychotic Agents; Brain-Derived Neurotrophic Factor; Clozapine; Enzyme-Linked Immunosorbe | 2011 |
Hyperosmolar hyperglycemic state associated with ziprasidone treatment: a case report.
Topics: Adult; Antipsychotic Agents; Humans; Hyperglycemia; Male; Osmolar Concentration; Piperazines; Risper | 2011 |
Schizophrenia-like psychosis associated with right lacunar thalamic infarct.
Topics: Adult; Antipsychotic Agents; Delusions; Humans; Male; Memory Disorders; Neuropsychological Tests; Ri | 2013 |
Angioedema - an unusual serious side effect of risperidone injection.
Topics: Angioedema; Antipsychotic Agents; Deglutition Disorders; Dyspnea; Female; Humans; Middle Aged; Orbit | 2013 |
Ibuprofen and psychotic exacerbation.
Topics: Acute Disease; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antipsychotic Agents; Back Pain; Como | 2002 |
Delayed-onset nocturnal akathisia due to risperidone and levomepromazine: a case report.
Topics: Akathisia, Drug-Induced; Antipsychotic Agents; Circadian Rhythm; Female; Humans; Methotrimeprazine; | 2002 |
A case of neuroleptic malignant syndrome with clozapine and risperidone.
Topics: Adult; Antipsychotic Agents; Clozapine; Humans; Male; Neuroleptic Malignant Syndrome; Risperidone; S | 2002 |
Cerebral metabolism and risperidone treatment in schizophrenia.
Topics: Adult; Antipsychotic Agents; Cerebellum; Cerebral Cortex; Chronic Disease; Energy Metabolism; Female | 2003 |
Risperidone-induced retrograde ejaculation: case report and review of the literature.
Topics: Antipsychotic Agents; Chronic Disease; Dose-Response Relationship, Drug; Ejaculation; Humans; Male; | 2004 |
Tardive dyskinesia following brief exposure to risperidone--a case study.
Topics: Adult; Antipsychotic Agents; Brain; Dyskinesia, Drug-Induced; Humans; Male; Risperidone; Schizophren | 2004 |
[Effect of clozapine and risperidone on serum cytokine levels in patients with first-episode paranoid schizophrenia].
Topics: Adolescent; Adult; Antipsychotic Agents; Clozapine; Cytokines; Female; Humans; Interleukin-18; Inter | 2004 |
Risperidone-induced morning pseudoneutropenia.
Topics: Adult; Antipsychotic Agents; Circadian Rhythm; Female; Humans; Leukocyte Count; Neutropenia; Neutrop | 2005 |
Risperidone-induced immunoallergic hepatitis.
Topics: Adult; Chemical and Drug Induced Liver Injury; Drug Hypersensitivity; Humans; Male; Risperidone; Sch | 2005 |
Zotepine-induced catatonia as a precursor in the progression to neuroleptic malignant syndrome.
Topics: Antipsychotic Agents; Blood Chemical Analysis; Catatonia; Dibenzothiepins; Disease Progression; Feve | 2005 |
Regional cerebral blood flow changes in a patient with delusional parasitosis before and after successful treatment with risperidone: a case report.
Topics: Aged, 80 and over; Antipsychotic Agents; Cerebrovascular Circulation; Humans; Magnetic Resonance Ima | 2006 |
Improved long-term outcome with long-acting risperidone treatment of chronic schizophrenia with prior partial response.
Topics: Antipsychotic Agents; Chronic Disease; Delayed-Action Preparations; Humans; Male; Middle Aged; Rispe | 2006 |
Risperidone alternative for a schizophrenic patient with olanzapine-exacerbated diabetic mellitus.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Diabetes Mellitus, Type 2; Disease Progression; Humans | 2006 |
Acquired long QT syndrome: risperidone-facilitated triggered activity and Torsades de Pointes during complete AV block. I.
Topics: Aged, 80 and over; Antipsychotic Agents; Electrocardiography; Fatal Outcome; Female; Heart Block; Hu | 2007 |
Reversal of antipsychotic-induced hyperprolactinemia, weight gain, and dyslipidemia by aripiprazole: A case report.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Dyslipidemias; Female; Humans; Hyperprolactinemia; Obesit | 2006 |
Follow-up of a pregnancy with risperidone microspheres.
Topics: Adult; Antipsychotic Agents; Birth Weight; Female; Humans; Infant; Infant, Newborn; Microspheres; Pr | 2006 |
Risperidone-induced sialorrhea responsive to biperiden treatment.
Topics: Administration, Oral; Adolescent; Antipsychotic Agents; Biperiden; Dose-Response Relationship, Drug; | 2007 |
Multi-drug overdose risperidone, ziprasidone, valproate, trihexyphenidyl, and clonazepam.
Topics: Adult; Antipsychotic Agents; Clonazepam; Drug Overdose; Drug Prescriptions; Female; Humans; Piperazi | 2007 |
Risk of discontinuation of atypical antipsychotic agents in the treatment of schizophrenia.
Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Dibenzothiazepines; Female; Follow-Up Studies | 2008 |
Atypical antipsychotic drugs in the treatment of delusional parasitosis.
Topics: Adolescent; Adult; Aged; Amisulpride; Antipsychotic Agents; Benzodiazepines; Female; Follow-Up Studi | 2007 |
Metabolic syndrome in drug-naïve first-episode psychosis treated with atypical antipsychotics.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Blood Pressure; Cross-Sectional Studies; Dibenzothiaze | 2007 |
Association between priapism and concurrent use of risperidone and Ginkgo biloba.
Topics: Adult; Antipsychotic Agents; Drug Interactions; Ginkgo biloba; Humans; Male; Priapism; Risperidone; | 2007 |
[Remission with long-lasting antipsychotic agent].
Topics: Antipsychotic Agents; Female; Humans; Middle Aged; Patient Compliance; Risperidone; Schizophrenia, P | 2007 |
Three cases of schizophrenia for which olanzapine was effective after early acute phase.
Topics: Acute Disease; Adult; Antipsychotic Agents; Benzodiazepines; Drug Therapy, Combination; Female; Foll | 2008 |
Cross-tapering clozapine and risperidone.
Topics: Adult; Antipsychotic Agents; Clozapine; Drug Monitoring; Female; Humans; Risperidone; Schizophrenia, | 1995 |
Risperidone-induced priapism.
Topics: Antipsychotic Agents; Chronic Disease; Drug Therapy, Combination; Humans; Isoxazoles; Lithium Carbon | 1994 |
Re: Hypomania associated with risperidone.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Chronic Disease; Female; Humans; Isoxazoles; Piperidi | 1995 |
Risperidone augmentation of clozapine.
Topics: Adult; Antipsychotic Agents; Clozapine; Drug Therapy, Combination; Humans; Isoxazoles; Male; Piperid | 1995 |
Two cases of risperidone-induced neuroleptic malignant syndrome.
Topics: Aged; Antipsychotic Agents; Humans; Isoxazoles; Male; Neuroleptic Malignant Syndrome; Piperidines; R | 1995 |
Is risperidone a substitute for clozapine for patients who do not respond to neuroleptics?
Topics: Adult; Antipsychotic Agents; Clozapine; Drug Administration Schedule; Drug Therapy, Combination; Fem | 1995 |
Risperidone-induced dystonic reaction.
Topics: Adult; Antipsychotic Agents; Dystonia; Humans; Male; Ocular Motility Disorders; Risperidone; Schizop | 1996 |
Weight gain associated with risperidone.
Topics: Adolescent; Antipsychotic Agents; Female; Humans; Male; Risperidone; Schizophrenia, Paranoid; Weight | 1996 |
Withdrawal-emergent dyskinesia in a patient on risperidone undergoing dosage reduction.
Topics: Adult; Antipsychotic Agents; Dyskinesia, Drug-Induced; Humans; Male; Risperidone; Schizophrenia, Par | 1996 |
[Remission of schizophrenic psychosis with negative symptoms with risperidone].
Topics: Adult; Antipsychotic Agents; Combined Modality Therapy; Depression; Hallucinations; Humans; Male; Ps | 1996 |
Acute dystonia induced by rapid increase in risperidone dosage.
Topics: Acute Disease; Adult; Antipsychotic Agents; Dystonia; Humans; Male; Risperidone; Schizophrenia, Para | 1996 |
Risperidone-reserpine combination in refractory psychosis.
Topics: Adult; Aged; Antipsychotic Agents; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Psy | 1996 |
A case report of risperidone-induced obsessive-compulsive symptoms.
Topics: Adult; Antipsychotic Agents; Clomipramine; Drug Therapy, Combination; Female; Humans; Obsessive-Comp | 1997 |
Risperidone and hyponatremia: a case report.
Topics: Antipsychotic Agents; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Middle Aged; Risperido | 1997 |
Risperidone-associated agranulocytosis.
Topics: Adult; Agranulocytosis; Antipsychotic Agents; Female; Humans; Risperidone; Schizophrenia, Paranoid | 1998 |
Olanzapine treatment in patients with typical and atypical neuroleptic-associated agranulocytosis.
Topics: Adult; Agranulocytosis; Antipsychotic Agents; Benzodiazepines; Clopenthixol; Dose-Response Relations | 1998 |
Prolactogenic effects of risperidone in male patients--a preliminary study.
Topics: Antipsychotic Agents; Chronic Disease; Dose-Response Relationship, Drug; Drug Administration Schedul | 1998 |
Risperidone-induced hepatotoxicity.
Topics: Adult; Antipsychotic Agents; Chemical and Drug Induced Liver Injury; Female; Humans; Liver Function | 1998 |
[The risperidone-associated neuroleptic malignant syndrome in a pediatric patient].
Topics: Adolescent; Antipsychotic Agents; Female; Humans; Neuroleptic Malignant Syndrome; Risperidone; Schiz | 1998 |
Risperidone-induced rabbit syndrome: an unusual movement disorder caused by an atypical antipsychotic.
Topics: Adult; Antipsychotic Agents; Dyskinesia, Drug-Induced; Humans; Male; Risperidone; Schizophrenia, Par | 1999 |
Catatonia under medication with risperidone in a 61-year-old patient.
Topics: Antipsychotic Agents; Catatonia; Clozapine; Delusions; Dose-Response Relationship, Drug; Female; Hum | 1999 |
Risperidone and associated amenorrhea: a report of 5 cases.
Topics: Adult; Amenorrhea; Antipsychotic Agents; Bipolar Disorder; Female; Follow-Up Studies; Humans; Mental | 1999 |
Risperidone-induced anxiety might also develop 'awakening' phenomenon.
Topics: Adult; Antipsychotic Agents; Anxiety; Humans; Male; Risperidone; Schizophrenia, Paranoid; Sleep Wake | 1999 |
[Diminution of hand writing area and D2-dopamine receptor blockade. Results from treatment with typical and atypical neuroleptics].
Topics: Adult; Aged; Antipsychotic Agents; Benzamides; Clozapine; Dopamine Antagonists; Female; Haloperidol; | 2000 |
Risperidone in the treatment of delusional parasitosis: a case report.
Topics: Aged; Antipsychotic Agents; Humans; Male; Risperidone; Schizophrenia, Paranoid | 1997 |
Olanzapine appears haematologically safe in patients who developed blood dyscrasia on clozapine and risperidone.
Topics: Aged; Antipsychotic Agents; Benzodiazepines; Clozapine; Drug Monitoring; Humans; Leukopenia; Male; N | 2000 |
Risperidone-induced tardive dyskinesia.
Topics: Adult; Anti-Dyskinesia Agents; Antipsychotic Agents; Biperiden; Blepharospasm; Botulinum Toxins; Clo | 2000 |
Risperidone-induced retrograde ejaculation.
Topics: Adult; Antipsychotic Agents; Ejaculation; Genital Diseases, Male; Humans; Male; Risperidone; Schizop | 2001 |
Pancreatitis and cholestatic hepatitis induced by risperidone.
Topics: Adult; Antipsychotic Agents; Chemical and Drug Induced Liver Injury; Cholestasis; Humans; Male; Panc | 2001 |
Three challenges and a rechallenge episode of angio-oedema occurring in treatment with risperidone.
Topics: Angioedema; Antipsychotic Agents; Female; Humans; Middle Aged; Orbital Diseases; Recurrence; Risperi | 2001 |
Exacerbation of idiopathic priapism with risperidone-citalopram combination.
Topics: Adrenergic Antagonists; Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Cital | 2002 |